| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $41.11B | -18.5% |
| Cost of Revenue | $35.85B | -18.2% |
| R&D Expense | $130.0M | +4.8% |
| SG&A Expense | $1.56B | +18.9% |
| Operating Income | $3.05B | -40.1% |
| Interest Expense | $477.0M | +66.2% |
| Pre-tax Income | $2.63B | -45.0% |
| Income Tax | $501.0M | -43.2% |
| Net Income | $2.12B |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.39B | +57.6% |
| Short-term Investments | $2.43B | — |
| Inventory | $4.76B | -0.8% |
| Current Assets | $13.15B | +11.0% |
| Total Assets | $37.00B | +1.7% |
| Current Liabilities | $7.15B | +5.8% |
| Long-term Debt | $10.33B | -2.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $4.94B | -19.2% |
| Capital Expenditures | $1.53B | -19.0% |
| Investing Cash Flow | -$1.78B | +10.1% |
| Financing Cash Flow | -$1.95B | +42.8% |
| Free Cash Flow | $3.41B | -19.3% |
| -45.5% |
| EPS (Basic) | $6.48 | -45.3% |
| EPS (Diluted) | $6.46 | -45.3% |
| Stockholders' Equity |
| $12.93B |
| +2.5% |